Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial
Nicola Curry(National Health Service), Simon Stanworth(Oxford BioMedica (United Kingdom)), James B. Ray(John Radcliffe Hospital), Ana Sabrina Mora(NHS Blood and Transplant), Elinor Curnow(NHS Blood and Transplant), Ross Davenport(Queen Mary University of London), Claire Foley(NHS Blood and Transplant), Henna Wong(Churchill Hospital), Matthew J. Reed(Edinburgh Royal Infirmary), Phil Moss, Agne Zarankaite(NHS Blood and Transplant), Alison Deary(NHS Blood and Transplant), Renate Hodge(NHS Blood and Transplant), Suzanne Kellett(University Hospital Southampton NHS Foundation Trust), Valerie Hopkins(NHS Blood and Transplant)
Cited by 107
Related Papers
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
|Cochrane Database of Systematic Reviews|2016|1.2k
Acute coagulopathy of trauma: mechanism, identification and effect
|Current Opinion in Critical Care|2007|569
Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes
|Journal of Thrombosis and Haemostasis|2012|554
Functional definition and characterization of acute traumatic coagulopathy
|Critical Care Medicine|2011|524
The incidence and magnitude of fibrinolytic activation in trauma patients
|Journal of Thrombosis and Haemostasis|2012|481